ACE2 and metabolic dysfunction-associated steatotic liver disease: Our results indicate that increased ACE2 levels are higher in patients with NAFLD compared to those with viral hepatitis and are more elevated in those who experienced SAR-Cov-2 infection compared to the counterpart.